We are at the forefront of using hormones to treat obesity and related medical problems with the advent of GLP-1s.
Join us in accelerating research and advancing treatment for the more than 1 billion people worldwide living with obesity. |
|
NEWS: Endocrine Society releases Scientific Statement on obesity that identifies areas of needed research. |
Obesity Fellows Program: A prestigious experience focused on the latest evidence-based approaches in obesity care. Fellows will hear from world renowned experts in obesity care, engage in small-group case discussions, and have direct access to leading experts in the field.
Urge Your Member of Congress to Cosponsor the Treat and Reduce Obesity Act (TROA): This legislation would allow coverage of anti-obesity medications (AOMs) currently prohibited in the Medicare statute and expand access to intensive behavioral therapy (IBT) for obesity.
Talking Obesity with Daniel Drucker, MD: Story of A Pioneer in Obesity Care
Recent Statements, Research, Advocacy, Guidelines & More
Research
Thematic issue on Obesity (research): Selection of recent journal articles that advance understanding of obesity and the roles of diet and exercise in metabolic health.
Closing the Obesity Diagnosis Gap: A New EHR-Based Measure Could Improve Population Health Outcomes (research): A new obesity measure championed by authors of a recent Journal of Clinical Endocrinology & Metabolism paper.
Journal of the Endocrine Society (JES): Obesity and Adipocyte Biology (research): List of articles published in JES on obesity and adipocyte biology and related topics.
JES Obesity Open Call for Submissions(research): Researchers are encouraged to submit obesity or obesogen research on the topic to Journal of the Endocrine Society.
Obesity Playbook (advocacy): Educational resources for Congressional staff on obesity and health. Playbook includes up-to-date facts and figures, state of the science, and policy recommendations.
Obesity Special Interest Group (SIG) (community): Group of members interested in obesity education, research, networking activities, and more.
2026 Obesity Fellows Program (education): Obesity Fellows program, September 18-19, 2026, is an exclusive, application-based, educational activity.
Strategies for Obesity and Weight Management at CEU 2026 (education): Clinical Endocrinology Update (CEU) 2026 sessions, online Oct. 22-24, addresses GLP-1-induced sarcopenia and preventing post-treatment weight regain.
Two Generations, One Challenge: Confronting Obesity in Pregnancy and Childhood's Metabolic Outcomes (education): Virtual of a live webinar.
Reprogrammed by Chemicals: The Epigenetic Link Between Environmental Exposure and Obesity (education): Member-only webinar sponsored by the Society’s Obesity and EDCs Special Interest Groups.
Defining Disease or Delaying Care? A Conceptual and Clinical Appraisal of the Lancet Obesity Framework (clinical practice guideline): Response to Lancet article that redefines obesity based not only on BMI but on whether excess body fat causes health problems.
Pharmacologic Management of Obesity (clinical practice guideline): Open comments for Pharmacologic Management of Obesity: An Endocrine Society Clinical Practice Guideline is in development.
Taste Changes with Semaglutide (podcast): Endocrine Feedback Loop podcast examining whether semaglutide alters taste recognition, tongue gene expression, and brain responses to food-related cues.
Step Counts Decline Among GLP-1 Users (video): People who lost weight with GLP-1 anti-obesity medications tended to log fewer daily steps.
Funding for the Center on Obesity was provided in part through support by Eli Lilly and Company.
